Sentinel lymph node biopsy for the T1 (thin) melanoma: Is it necessary?

Annals of Plastic Surgery

Volumn 50, Issue 6, 2003, Pages 601-606

  Nahabedian, Maurice Y ^a   Tufaro, Anthony P ^b   Manson, Paul N ^b   MacKay, Donald R ^b   Davison, Steven P ^b   Samaha, Fouad ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACRAL LENTIGINOUS MELANOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CLINICAL ARTICLE; EARLY CANCER; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SKIN SURGERY; THICKNESS; TUMOR GROWTH; TUMOR VOLUME; ULCER;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037607344     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SAP.0000069065.00486.1E     Document Type: Article

References (30)

1. Balch CM, Houghton AN, Sober AJ, et al. Cutaneous Melanoma. St. Louis: Quality Medical Publishing; 1998.
2. Clary BM, Brady MS, Lewis JJ, et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single institutional experience with an emphasis on recurrence. Ann Surg. 2001;233:250-258.
3. Wagner JD, Corbett L, Park HM, et al. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures. Plast Reconstr Surg. 2000;105:1956-1966.
4. Bachter D, Michl C, Buchels H, et al. The predictive value of the sentinel node in malignant melanomas. Recent Results Cancer Res. 2001;158:129-136.
5. Blaheta HJ, Schittek B, Breuninger H, et al. Detection of micrometastases in sentinel lymph nodes of patients with primary cutaneous melanoma. Recent Results Cancer Res. 2001;158:137-146.
6. Frahm SO, Schubert C, Parwaresch R, et al. High proliferative activity may predict early metastases of thin melanomas. Hum Pathol. 2001;32:1376-1381.
7. Pontikes LA, Temple WJ, Cassar SL. Influence of level and depth on recurrence rate in thin melanomas. Am J Surg. 1993;165:225-228.
8. Buttner P, Garbe C, Bertz J, et al. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer. 1995;75:2499-2506.
9. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol. 2001;19:2851-2855.
10. Reintgen DS, Rapaport DP, Tanabe KK, et al. Lymphatic mapping and sentinel lymphadenectomy. In: Balch CM, Houghton AN, Sober AJ, et al. eds. Cutaneous Melanoma. St. Louis: Quality Medical Publishing; 1998:227-244.
11. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO melanoma program experience. Ann Surg Oncol. 2000;7:469-474.
12. Balch CM, Buzaid AC, Soong SJ. Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;16:3635-3648.
13. Wrone DA, Tanabe KK, Cosimi AB, et al. Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases. Arch Dermatol. 2000;136:511-514.
14. Park KGM, Blessing K, McLaren KM, et al. Study of thin (<1.5 mm) malignant melanomas with poor prognosis. Br J Plast Surg. 1993;46;607-610.
15. Shaw HM, McCarthy SW, McCarthy WH, et al. Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases. Histopathology. 1989;15:257-265.
16. Cook MG, Spatz A, Brocker EB, et al. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group. J Pathol. 2002;197:188-193.
17. Muller MG, van Leewen PA, van Diest PJ, et al. No indication for performing sentinel lymph node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm. Melanoma Res. 2001;11:303-307.
18. Temple CL, Scilley CG, Engel CJ, et al. Sentinel node biopsy in melanoma using technetium-99m rhenium colloid: the London experience. Ann Plast Surg. 2000;45:491-499.
19. Harlow SP, Krag DN, Ashikaga T, et al. Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicenter study. Melanoma Res. 2001;11:45-55.
20. Owen SA, Sanders LL, Edwards LJ, et al. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV. Cancer. 2002;91:983-991.
21. Fearfield LA, Rowe A, Francis N, et al. Clinico-pathological features of relapsing very thin melanoma. Exp Dermatol. 2001;26:686-695.
22. Corsetti RL, Allen HM, Wanebo HJ. Thin < or = 1 mm level III, IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol. 2000;7:456-460.
23. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol. 1998;16:2253-2260.
24. Slingluff CL, Vollmer RT, Reintgen DS, et al. Lethal "thin" malignant melanoma: identifying patients at risk. Ann Surg. 1988;208:150-161.
25. Slingluff CL, Seigler HF. Thin malignant melanoma: risk factors and clinical management. Ann Plast Surg. 1992;28:89-94.
26. Rayatt SS, Hettiaratchy SP, Key A, et al. Psychosocial benefits of sentinel lymph node biopsy in the management of cutaneous malignant melanoma. Br J Plast Surg. 2002;55:95-99.
27. Vollmer RT. Malignant melanoma: a multivariate analysis of prognostic factors. Pathol Annu. 1989;24:383-407.
28. Holbrook KA, Wolff K. Structure and development of skin. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., eds. Dermatology in General Medicine. New York: McGraw Hill Book Company; 1987:93-131.
29. Demierre MF. Thin melanomas and regression, thick melanomas and older men. Arch Dermatol. 2002;138:678-682.
30. Bedrosian I, Faries MB, Guery D, et al. Incidence of sentinel lymph node metastases in patients with thin primary melanoma (< 1mm) with vertical growth phase. Ann Surg Oncol. 2000;7:262-267.